Global Hot Flashes Treatment Market Growth 2025-2031

The global Hot Flashes Treatment market size is predicted to grow from US$ 13140 million in 2025 to US$ 16270 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

Hot flashes are typically characterized by sudden mild or intense body heat because of the changes occurrence by hormones. This occurs due to decreased level of estrogens. The phenomenon of host flashes in men, young women, or pregnant ladies is projected because of medical conditions that may also disrupt the body?s ability to regulate temperature. It is mostly seen in menopause conditions. The hot flashes are generally belief to be lasting for 30 minutes. The common symptoms associated with hot flashes include feeling of anxiety, rapid heartbeat, perspiration on upper body, red and blotchy skin and palpitations.

Factors such as rising incidence of vasomotor symptoms during menopause and technological advancements in developing new therapeutic agents are driving the market growth. For example, according to an article published in the June 2022 issue of Women"s Health, an online survey was conducted in the United Kingdom between 19 and 26 May 2021 to assess attitudes, years of knowledge and symptoms. According to observations, 68.9% of women experienced mood swings during menopause, 68.3% experienced brain fog, and 66.8% experienced fatigue symptoms. In addition, other psychological problems, including irritability, poor concentration, poor memory, lack of motivation, decreased self-confidence and anxiety, can affect their quality of life.

According to an article published in September 2021 in the International Journal of Reproductive Biomedicine, it has been observed that around 50-85% of women worldwide experience menopausal heat symptoms. Furthermore, according to the same source, the prevalence of menopausal hot flash symptoms is reported to be highest in Western countries and lowest in Asian countries. This is expected to spur the demand for hormonal and non-hormonal therapies for the treatment of menopausal symptoms, thereby boosting the market growth.

LP Information, Inc. (LPI) ' newest research report, the ?Hot Flashes Treatment Industry Forecast? looks at past sales and reviews total world Hot Flashes Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Hot Flashes Treatment sales for 2025 through 2031. With Hot Flashes Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hot Flashes Treatment industry.

This Insight Report provides a comprehensive analysis of the global Hot Flashes Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hot Flashes Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hot Flashes Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hot Flashes Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hot Flashes Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Hot Flashes Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Oral

Parenteral

Segmentation by Application:

Hospital

Specialist Clinic

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

AbbVie Inc

Bausch Health Companies Inc

Teva Pharmaceutical Industries Ltd

Cipla Inc

Lupin

Sun Pharmaceuticals Industries Ltd

Hikma Pharmaceuticals PLC

Boehringer Ingelheim International GmbH

Sanofi

AstraZeneca

GSK Plc

Pfizer Inc

Novartis AG

Mylan N.V

Hisamitsu Pharmaceutical Co.,Inc

Merck & Co., Inc

TherapeuticsMD, Inc

Lilly

Emcure Pharmaceuticals Limited

Bayer AG

Novo Nordisk Corporation

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hot Flashes Treatment market?

What factors are driving Hot Flashes Treatment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hot Flashes Treatment market opportunities vary by end market size?

How does Hot Flashes Treatment break out by Type, by Application?


Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports